Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 164,086 | 35,723 | 42,649 | 101,099 | 132,423 |
| Marketable Securities | 365,125 | 466,969 | 568,564 | 559,915 | 632,969 |
| Receivables | 19,361 | 16,292 | 3,702 | 2,485 | 3,039 |
| Inventories | 11,411 | N/A | N/A | N/A | N/A |
| TOTAL | $571,519 | $526,255 | $616,434 | $667,318 | $772,073 |
| Non-Current Assets | |||||
| PPE Net | 564 | 586 | 717 | 894 | 786 |
| Intangibles | 11,214 | 4,622 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,525 | 9,163 | 4,333 | 3,929 | 3,292 |
| TOTAL | $23,303 | $14,371 | $5,050 | $4,823 | $4,078 |
| Total Assets | $594,822 | $540,626 | $621,484 | $672,141 | $776,151 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,724 | 6,283 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 9,479 | 6,348 | 2,209 | 2,139 | 3,925 |
| Accrued Expenses | 45,183 | 32,833 | 9,793 | 9,816 | 12,137 |
| Other current liabilities | 19,965 | 11,117 | N/A | N/A | N/A |
| TOTAL | $82,231 | $58,244 | $13,974 | $13,161 | $16,925 |
| Non-Current Liabilities | |||||
| Long Term Debt | 47,208 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 159,667 | 18,594 | 2,388 | 3,904 | 13,229 |
| TOTAL | $206,875 | $18,594 | $2,388 | $3,904 | $13,229 |
| Total Liabilities | $289,106 | $76,838 | $16,362 | $17,065 | $30,154 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 347,597 | 338,679 | 219,046 | 218,804 | 219,059 |
| Common Shares | 1,421,273 | 1,373,958 | 947,745 | 927,604 | 909,985 |
| Retained earnings | -1,115,370 | -910,743 | -342,804 | -267,002 | -162,803 |
| Other shareholders' equity | -187 | 573 | 181 | -5,526 | -1,185 |
| TOTAL | $305,716 | $463,788 | $605,122 | $655,076 | $745,997 |
| Total Liabilities And Equity | $594,822 | $540,626 | $621,484 | $672,141 | $776,151 |